glp 1 mash approval glp-1 liver Current status of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatotic disease: A clinical perspective GLP-1 Fatty Liver Approval: – Wegovy Is Now the Second

Pregnancy risks associated with obesity

Fluid timing : Distribute fluid intake throughout the day, with individualized recommendations regarding evening intake to balance hydration needs with potential nocturia

doi: 10.1080/00325481.2015.1090295

If your goal is to increase your dietary fibre, make sure we're doing so gradually and with an increase in water

No app is perfectly precise, but tracking consistently even with small margins of error gives a useful picture of patterns over time, which is what matters most.

The cardiorenal protective effects of finerenone, a novel nonsteroidal mineralocorticoid receptor antagonist (MRA), in patients with diabetes and CKD have also been revealed in recent years [11]